Christopher M. Reid

Christopher M. Reid

Auto-generated profile, based on publicly available information

Christopher M. Reid

Division of Plastic Surgery, University of California San Diego, La Jolla, CA, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
SBSummer A. Bs Beeson
Summer A. Bs Beeson
DNDaniel Neubauer
Daniel Neubauer
RCRichard Calvo
Richard Calvo
MSMichael Sise
Michael Sise
MMMatthew Md Martin
Matthew Md Martin
CRChris M. Reid
Chris M. Reid
Background: Mortality rates following major lower extremity amputations (LEAs) 30 days–365 days postoperative have decreased, but 5-year rates remain high at 40.4%–70%. These data may not reflect recent advances in peripheral arterial disease (PAD) care, and comorbidities of chronic PAD may lead to mortality more frequently than the amputation itself. Mortality rates between diabetic and nondiabetic patients were also analyzed. Methods: The California Office of Statewide Health Planning and Development hospital database was queried for patients admitted January 1, 2007–December 31, 2018. ICD-9-CM codes identified patients with vascular disease and an amputation procedure. Results: There were 26,669 patients. The 30-day, 90-day, 1-year, and 5-year major LEA mortality rates were 4.82%, 8.62%, 12.47%, and 18.11%, respectively. Weighted averages of 30-day, 90-day, 1-year, and 5-year major LEA mortality rates in the literature are 13%, 15.40%, 47.93%, and 60.60%, respectively. Mortality risk associated with vascular disease after amputation (hazard ratio = 22.07) was 11 times greater than risk associated with amputation-specific complications from impaired mobility (hazard ratio = 1.90; P < 0.01). Having diabetes was associated with lower mortality at 30 days, 90 days, and 1 year (P < 0.01) but not at 5 years (P = 0.22). Conclusions: This study suggests that people may be living longer after their major LEA than was previously thought. This study suggests that patients’ PAD may play a bigger role in contributing to their mortality than complications from loss of mobility postamputation. Although having diabetes was associated with lower postamputation mortality, the difference was no longer significant by 5 years.

21 April 2023 in Aesthetic Surgery Journal
Verified
Journal Article
Open access
PDF file
DNDaniel Najafali
Daniel Najafali
CHChandler Hinson
Chandler Hinson
JCJustin M Camacho
Justin M Camacho
LGLogan G Galbraith
Logan G Galbraith
RGRohun Gupta
Rohun Gupta
CRChris M Reid
Chris M Reid
The rise of artificial intelligence (AI) has revolutionized multiple disciplines within the healthcare sector, having large-scale impact within diagnostics, medical education, and clinical research. The latest breakthrough within AI that has caught the attention of many is ChatGPT or GPT-3.5 (OpenAI, San Francisco, CA), a large language model (LLM) that was released.1 ChatGPT is unique because it responds to inputs in a humanistic fashion, continuously learning from inputs and prior mistakes. These additional features, which enhance the abilities of ChatGPT, allow it to potentially be applied to other avenues including grant writing. We aimed to apply ChatGPT to grant writing, with the future implications of chatbots helping secure R01 and other application-based grants.

23 November 2022 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
SMSuat Morkuzu
Suat Morkuzu
MOMehmet Ozdemir
Mehmet Ozdemir
GLGarrison A. Leach
Garrison A. Leach
MKMuholan Md Kanapathy
Muholan Md Kanapathy
AMAfshin FRCS(Plast) Mosahebi
Afshin FRCS(Plast) Mosahebi
CRChris M. Reid
Chris M. Reid
Background: Breast augmentation is one of the most common aesthetic surgical procedures. Tissue expansion followed by permanent implants is the most frequent postmastectomy breast reconstruction method. Implant contamination remains a critical problem with these procedures‚ resulting in acute infection as well as capsular contracture. To reduce the risk of implant contamination, the “no-touch technique” utilizing the Keller funnel has been adopted by many surgeons. This systematic review aims to investigate the advantages of the Keller funnel method for breast augmentation–reconstruction. Methods: A systematic review of PubMed, Embase, the Cochrane database, and Google Scholar was performed between 2005 and 2021. All clinical-based, retrospective and prospective studies utilizing the Keller funnel method for breast implant insertion were selected. Results: Six studies were identified for evaluation: five were retrospective cohorts and one was a prospective trial. No randomized controlled trials were found. Outcomes reported included lower rates of capsular contracture (RR, 0.42; P = 0.0006; 95% CI, 0.25–0.69), shorter incision lengths (35.5 ± 2.1 mm), less insertion time (mean = 6 seconds), and decreased complications, and one paper reported ultimately greater patient satisfaction with outcomes (BREAST-Q Score: 92%). Conclusions: This review suggests that the Keller funnel is a useful method for no-touch breast augmentation and reconstruction surgery. The Keller funnel reduces subsequent capsular contracture rate, surgical time, and incision length and allows for easier insertion. However, our findings support recommendation of a prospective randomized controlled clinical trial with larger population size and follow-up intervals.

16 May 2023 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
VSVictoria Stoffel
Victoria Stoffel
JSJalene Y. Shim
Jalene Y. Shim
SPSalvatore J. Md Pacella
Salvatore J. Md Pacella
AGAmanda A. Gosman
Amanda A. Gosman
CRChris M. Reid
Chris M. Reid
Background: Over the past decade across multiple surgical specialties, Medicare reimbursement rates have remained stagnant, failing to keep pace with inflation. An internal comparison of subspecialties within plastic surgery has not yet been attempted. The goal of this study was to investigate the trends in reimbursement from 2010 to 2020 and compare across the subspecialties of plastic surgery. Methods: The Physician/Supplier Procedure Summary was used to extract the annual case volume for the top 80% most-billed CPT codes within plastic surgery. Codes were defined into the following subspecialties: microsurgery, craniofacial surgery, breast surgery, hand surgery, and general plastic surgery. The Medicare physician reimbursement was weighted by case volume. The growth rate and compound annual growth rate were calculated and compared against an inflation-adjusted reimbursement value. Results: On average, inflation-adjusted growth in reimbursement for the procedures analyzed in this study was −13.5%. The largest decrease in growth rate was within the field of microsurgery (−19.2%), followed by craniofacial surgery (−17.6%). These subspecialties also had the lowest compound annual growth rate (−2.11% and −1.91%, respectively). For case volumes, microsurgery increased case volumes by an average of 3% per year, whereas craniofacial surgery increased case volumes by an average of 5% per year. Conclusions: After adjusting for inflation, all subspecialties had a decrease in growth rate. This was particularly evident in the fields of craniofacial surgery and microsurgery. Consequently, practice patterns and patient access may be negatively affected. Further advocacy and physician participation in reimbursement rate negotiation may be essential to adjust for variance and inflation.

1 July 2014 in Journal of Surgical Research
Verified
Journal Article
Closed access
CRChris M. Reid
Chris M. Reid
DKDennis Y. Kim
Dennis Y. Kim
JMJess Mandel
Jess Mandel
ASAlan Smith
Alan Smith
VBVishal Bansal
Vishal Bansal

4 January 2024 in Aesthetic Surgery Journal Open Forum
Verified
Journal Article
Closed access
RCRobert Craig Clark
Robert Craig Clark
MRMcKay D Reese
McKay D Reese
PAPhilopatir Attalla
Philopatir Attalla
JCJustin M Camacho
Justin M Camacho
MHMilan M Hirpara
Milan M Hirpara
CRChris M Reid
Chris M Reid
Background: Mesh implants are frequently employed in alloplastic breast reconstruction. Notably, no mesh to date has FDA approval for this indication. Several synthetic meshes have been introduced with heterogeneous properties and outcomes. Objectives: This study aims to systematically review synthetic mesh use in alloplastic breast reconstruction, describe rates of short-term complications, and analyze these outcomes in reports comparing synthetic and biologic meshes. The authors hypothesized data from comparative and noncomparative studies would show no significant differences between synthetic and biological meshes. Methods: The authors conducted a systematic literature review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Thirty-one studies reporting the use of synthetic mesh and clinical outcomes were included. Eight studies directly comparing synthetic mesh and biological mesh were meta-analyzed for relative risk (RR). Nineteen noncomparative studies were analyzed for meta-rates. Outcomes, including seroma, infection, reoperation, and explant, were assessed on a per-breast basis. Resultant models were challenged for sensitivity and bias. Results: Meta-analysis of comparative studies demonstrated no difference in the risk of infection with synthetic mesh (RR = 0.53; 95% CI [0.26-1.10]), but a reduced risk of reoperation (RR = 0.54; 95% CI [0.33-0.89]) or explant (RR = 0.43; 95% CI [0.21-0.87]). Meta-analysis of noncomparative studies demonstrated rates of seroma = 3%; 95% CI [1%-6%], infection = 4%; 95% CI [3%-6%], reoperation = 10%; 95% CI [7%-13%], and explant = 3%; 95% CI [2%-5%]). Conclusions: Studies comparing synthetic and biologic meshes demonstrated noninferiority of synthetic in all outcomes assessed. Noncomparative studies demonstrated rates of seroma, infection, reoperation, and explant similar to literature values for biological mesh. Level of Evidence: 2 (Risk):